Empery Asset Management LP 13D and 13G filings for Kiromic BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-12 10:02 am Purchase | 2022-12-31 | 13G | Kiromic BioPharma, Inc. KRBP | Empery Asset Management LP | 163,268 9.990% | 163,268![]() (New Position) | Filing |
| 2022-01-13 10:37 am Sale | 2021-12-31 | 13G | Kiromic BioPharma, Inc. KRBP | Empery Asset Management LP | 0 0.000% | -33,333![]() (Position Closed) | Filing |
| 2021-07-06 10:00 am Purchase | 2021-06-29 | 13G | Kiromic BioPharma, Inc. KRBP | Empery Asset Management LP | 33,333 6.500% | 33,333![]() (New Position) | Filing |

